Insight

Mar 26, 2024, 04:50

The latest ASCO podcast on the rapid guideline update on endocrine and targeted therapy for HR+, HER2+ metastatic breast cancer – Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared on X/Twitter:

“Listen to the latest ASCO podcast where Dr. Angela DeMichele, Dr. Lynn Henry, and Dr. Harold Burstein discuss the rapid guideline update on endocrine and targeted therapy for HR+, HER2+ metastatic breast cancer.
Listen here.”

Source: Dana-Farber’s Breast Oncology Center /X

Angela DeMichele ASCO ASCO Guidelines podcast Breast Cancer cancer Dana-Farber Breast Oncology Center endocrine therapy Harold Burstein HR+/HER2- breast cancer Lynn Henry metastatic breast cancer OncoDaily Oncology targeted therapy

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage